Introduction {#bhw229s1}
============

Hemizygous microdeletion at chromosomal locus 22q11.2 is a copy number variation (CNV) that occurs in approximately 1:2000 births. It is associated with high incidence rates of cognitive impairment and neuropsychiatric disorders, including depression ([@bhw229C31]), obsessive-compulsive disorder ([@bhw229C29]), attentional-deficit hyperactivity disorder and autism ([@bhw229C60]). The deletion is the strongest known genetic risk factor for schizophrenia with approximately 40% of carriers developing psychosis ([@bhw229C75]).

Several genes within the deleted segment are involved in cortical development ([@bhw229C56]) and some 22q11.2 deletion syndrome (22q11.2DS) carriers exhibit structural aberrations within regions involved in higher-order cognitive functioning such as the prefrontal cortex (PFC), hippocampus, and dorsal striatum ([@bhw229C16]) as well as disrupted dopamine (DA) ([@bhw229C10]) and glutamate ([@bhw229C19]) signaling. Some of these structural abnormalities have also been reported in transgenic mouse models lacking the orthologous chromosomal segment ([@bhw229C24]).

22q11.2DS is associated with extensive cognitive impairments. 22q11.2DS is associated with mild to moderate reductions in IQ-scores and learning impairments are observed in 85--100% of carriers ([@bhw229C52]). Carriers can show deficits in cognitive domains such as visuospatial memory ([@bhw229C6]) working memory ([@bhw229C47]), attention ([@bhw229C8]) and cognitive flexibility ([@bhw229C50]). Domain specific cognitive impairments also appear to be independent of general intelligence ([@bhw229C77]).

Several transgenic mouse models of 22q11.2DS have been created ([@bhw229C51]) and cognitively phenotyped to varying extents by different research groups. Most encompass the full core region of the 22q11.1 deletion (Dgcr2-Hira), while others carry partial deletions (Table [1](#bhw229TB1){ref-type="table"}). Schizophrenia-relevant sensory and psychomotor behaviors have been reported as disrupted in several of these models. The Df(16)A^+/−^ mouse model has been shown to display baseline hyperactivity and an anxiogenic phenotype ([@bhw229C83]) while increased hyperactivity in response to MK-801 was reported in the Df/+ model ([@bhw229C43]). Similar to human carriers ([@bhw229C82]) the Df(16)A^+/−^, Df1/+ and LgDel models displayed reduced prepulse inhibition ([@bhw229C67]; [@bhw229C53]; [@bhw229C83]) while the Df1/+ mutant had a increased acoustic startle response ([@bhw229C67]). Table 1Cognitive functioning in the Df(h22q11)/+ mutant and other 22q11.2DS mouse models. ↓ impaired, ↑ improved,  ╳ no effect, − no data.ModelDf(h22q11)/+Df(16)A+/−LgDelDf1/+DeletionDgcr2-HiraDgcr2-HiraDgcr2-HiraDgcr14-Ufd1lZnf74-CtpStrainC57/Bl6NTacC57/Bl6JC57/Bl6NMixed C57/Bl6c-/c- ;129S5/SvEvBrd129SvEvTac or mixed 129SvEvTac ; Crl:NIHBL(S)BehaviorParadigmMemoryWater maze \<20 weeks╳−−╳^[a](#bhw229tfn1){ref-type="table-fn"}^−Water maze \>20 weeks╳╳^[b](#bhw229tfn2){ref-type="table-fn"}^−↓^[a](#bhw229tfn1){ref-type="table-fn"}^−Contextual fear conditioning╳↓^[c](#bhw229tfn3){ref-type="table-fn"}^╳^[d](#bhw229tfn4){ref-type="table-fn"}^↓^[e](#bhw229tfn5){ref-type="table-fn"}^╳^[f](#bhw229tfn6){ref-type="table-fn"}^TUNL -- pattern separation╳−−−−Auditory-cue fear conditioning╳↓^[c](#bhw229tfn3){ref-type="table-fn"}^╳^[d](#bhw229tfn4){ref-type="table-fn"}^╳^[e](#bhw229tfn5){ref-type="table-fn"}^╳^[f](#bhw229tfn6){ref-type="table-fn"}^Touchscreen PAL╳−−−−Novel object recognition╳╳^[g](#bhw229tfn7){ref-type="table-fn"}^−−−Touchscreen discrimination learning"Easy" discrimination↑−−−−"Difficult" discrimination╳−↓^[h](#bhw229tfn8){ref-type="table-fn"}^−−Working MemoryY-maze spontaneous alternation╳−−−−TUNL -- delay challenge↑−−−−Radial arm-maze╳−−−−T-maze non-match to sampleAcquisition↓↓^[c](#bhw229tfn3){ref-type="table-fn"}^ ╳^[i](#bhw229tfn9){ref-type="table-fn"}^−↓^[j](#bhw229tfn10){ref-type="table-fn"}^−Delay challenge╳−−−−Executive functionPVT -- Premature responses╳−−−−5CSRTT -- Premature responses╳−−−−Touchscreen extinction learning╳−−−−Touchscreen reversal learning"Easy" reversal↑−−−−"Difficult" reversal╳−↓^[h](#bhw229tfn8){ref-type="table-fn"}^−−AttentionPVT -- Reaction time╳−−−−PVT -- Correct responses╳−−−−5-CSRTT -- Accuracy╳−−−−5-CSRTT -- Omissions↑−−−−[^1][^2][^3][^4][^5][^6][^7][^8][^9][^10]

In earlier studies, learning and memory deficits have been reported in 22q11.2DS mouse models. The Df(16)A^+/−^ and Df(16)1+ mutants ([@bhw229C83]; [@bhw229C36]) had impaired spatial alternation learning in the T-maze although the impairment has not always been replicated ([@bhw229C80]). In the water maze, Df(16)1/+ mice ([@bhw229C23]) but not the Df(16)A^+/−^ mutant ([@bhw229C22]) showed age-dependent impairments. Recently, the LgDel mutant was shown to have improved early-phase reversal learning but impaired late-phase and overall touchscreen reversal learning as well as impaired discrimination performance ([@bhw229C59]). The Df(16)A^+/−^ and the Df1/+ models ([@bhw229C67]; [@bhw229C83]), but not the LgDel mouse ([@bhw229C53]), also showed impaired fear conditioning. Normal contextual and auditory fear-conditioning was nevertheless observed in a 22q11.2DS model carrying a smaller 150 kB deletion ([@bhw229C42]).

Didriksen et al. describes the development and basic characterization of a novel model of 22q11.2DS (Df(h22q11)/+) with a hemizygous deletion at the region on mouse chromosome 16 that correspond to the core region of the human 22q11.2 deletion ([@bhw229C90]). As expected, cortical mRNA expression of genes in the region is reduced approximately 50%. The model shows deficits in PPI and activity assays in response to stimulants in the absence of overt baseline motoric deficits, making it suitable for screening in assays of cognition.

Following on such findings, the current set of experiments investigated the extent and robustness of behavioral and cognitive deficits in this model with the ultimate aim of evaluating its potential for cognitive translational studies. To this end, four partners within the NEWMEDS collaboration (Innovative Medicines Initiative Grant Agreement No. 115008) have phenotyped the Df(h22q11)/+ mouse using an extensive battery of assays that depend on neural structures compromised in 22q.11.2DS and 22q.11.2DS mouse models ([@bhw229C24]). The test battery contained several touchscreen assays that parallel the computerized tasks used with patients ([@bhw229C14]; [@bhw229C37]) and are sensitive to deficits of rodent models of neuropsychopathology ([@bhw229C5]; [@bhw229C13]; [@bhw229C84]; [@bhw229C30]; [@bhw229C72]; [@bhw229C63]; [@bhw229C26]; [@bhw229C57]; [@bhw229C71]; [@bhw229C41]). This represents the most extensive report of cognitive functioning in a 22q11.2DS transgenic mouse model to date (see Table [1](#bhw229TB1){ref-type="table"}).

Method {#bhw229s2}
======

Animals {#bhw229s2a}
-------

The generation of the Df(h22q11)/+ mouse is described in [@bhw229C90]. Df(h22q11)/+ mice were of c57BL/6NTac background. As 22q11.2DS models generated by others ([@bhw229C53]; [@bhw229C83]), the hemizygous deletion of the Df(h22q11)/+ model extend between Dgcr2-Hira on mouse chromosome 16 and encompass orthologs of all functional genes on the critical human 22q11.2 locus with exception of clathrin heavy polypeptide-like 1 (*CLTCL*) which appears absent in the mouse genome ([@bhw229C11]). The mouse region also includes *Igll1* that is not part of the human region and has not previously been linked to behavior or cognition in the mouse. Transcriptional changes in the Df(h22q11)/+ model was confirmed by cortical RNAseq analysis and microarray analysis of gene products from the deleted segment; detected products were decreased to around 50% of the expression in WT mice ([@bhw229C90]).

The experiments used 8 cohorts of animals. The age of animals at the start of each experiment and sample sizes for each experiment are shown in Figure [1](#bhw229F1){ref-type="fig"} and the legend of Figure [1](#bhw229F1){ref-type="fig"}, respectively. Cohorts 1--5 and 8 consisted of male mice; cohorts 6--7 consisted of male and female mice. Animals were group-housed (with the exception of Cohort 2 and 8 which were single-housed prior to T-maze and radial arm maze experiments) with ad libitum access to water under stable temperature and humidity conditions. Deficits in acquisition of T-maze delayed non-match to sample has previously been reported in a single-housed 22q11.2DS mouse model. We therefore single-housed Cohort 2 for 7 weeks prior to the T-maze experiment to evaluate the role of housing condition in producing a phenotype in this task. Prior to behavioral training, animals were food deprived to about 85% of their free-feeding weight. Cohorts 1--2 and 8 were housed under a reversed 12 h light/dark cycle (lights on at 7 p.m.). Cohorts 3--7 were housed under a standard 12 h light/dark cycle (lights off at 7 p.m.). All studies were carried out in accordance with European Union regulation (directive 2010/63 of 22 September 2010), UK Animals (Scientific Procedures) Act 1986 and UK Animals (Scientific Procedures) Act 1986 Amendment Regulations 2012, and were approved by the Danish National Committee for Ethics in Animal Experimentation and German Committee on Animal Care and Use. Figure 1.Age at the start of each experiment of 8 cohorts of Df(h22q11)/+ and WT littermates. Cohort 1 was tested on the 5-CSRTT, PAL, Extinction (all WT *N* = 16, TG *N* = 16) and T-maze (WT *N* = 10, TG N = 10). Cohort 2 was tested on reversal learning, TUNL, object recognition (all WT *N* = 16, TG *N* = 16) and T-maze (WT *N* = 11, TG N = 14). Cohort 3 was tested in the Y-maze (WT *N* = 15, TG *N* = 16), automated T-maze (WT *N* = 13, TG *N* = 16) and the rPVT (WT *N* = 13, TG *N* = 16). Cohort 4 (WT *N* = 16, TG *N* = 16) and Cohort 5 (WT *N* = 10, TG *N* = 8) were tested in the water maze. Cohort 6 (WT *N* = 24, TG *N* = 24) was tested in auditory fear conditioning. Cohort 7 (WT *N *= 20, TG *N* = 20) was tested on context-dependent fear conditioning. Cohort 8 (WT *N* = 16, TG *N* = 16) was tested in the radial-arm maze.

Procedures {#bhw229s2b}
----------

### Attention and Behavioral Inhibition {#bhw229s2b_1}

#### Touchscreen 5-choice serial reaction time task (5-CSRTT) {#bhw229s2b_1a}

All touchscreen assays were performed using 32 chambers (Campden Instruments, Loughborough, UK) with associated software (Abet II, Lafayette Instruments, Lafayette, IN, USA) described in detail elsewhere ([@bhw229C55]). The 5-CSRTT measures attention and impulsivity, cognitive domains disrupted in schizophrenia ([@bhw229C40]) and 22q11.2DS ([@bhw229C50]). The task is sensitive to attentional and impulsive disruptions in mouse models of neuropsychiatric disorders ([@bhw229C89]; [@bhw229C35]; [@bhw229C72]; [@bhw229C61]) and has been described extensively elsewhere ([@bhw229C72]; [@bhw229C55]). Briefly, animals were trained to respond to a white-square stimulus using a 2 s stimulus durations (SD), 40 trial session length and 5 s delay. Once acquired, the animals were assessed on a series of probe tests. This included tests of decreased SDs (1.6, 1, 0.8, 0.6, 0.4, 0.2 s) increasing delays (7, 9, 11, 13 s) and tests of increased session length (140 trials) with decreasing SDs (1.6, 1, 0.8, 0.6 s). The main dependent variables where percent accuracy, percent omissions, percent premature responses, percent perseverative responses, correct response latency, and reward retrieval latency.

#### Rodent psychomotor vigilance task (rPVT) {#bhw229s2b_1b}

The rPVT assesses impulsive control and is described elsewhere ([@bhw229C26]). Task performance is sensitive to disruptions in rodent models of schizophrenia ([@bhw229C26]). Briefly, a trial started with the illumination of the houselight (preparatory cue) followed by a variable interval (VI5s; range: 4--6 s) and the subsequent illumination of the magazine light for 10 s (imperative cue). Head entries into the magazine during the imperative cue were rewarded while head entries during the preparatory cue were scored as premature and resulted in a 5 s time-out. To assess impulsivity, probe-tests were performed at which length of the interval between the imperative and preparatory cues were extended from VI5s (range: 4--6 s) to VI10s (9--11 s) and VI15 s (14--16 s). The main dependent variable was percent premature responses. The number of correct responses, omissions and head entries, correct response latency and premature response latency was also collected for each mouse.

### Cognitive Flexibility {#bhw229s2b_2}

#### Touchscreen discrimination and reversal learning {#bhw229s2b_2a}

Reversal learning measures cognitive flexibility which is disrupted in schizophrenia ([@bhw229C49]) and 22q11.2DS ([@bhw229C50]) and the LgDel mouse model ([@bhw229C59]). The task is extensively described elsewhere ([@bhw229C34]; [@bhw229C55]). The task has been shown to be sensitive to transgenic mouse models schizophrenia ([@bhw229C63]) and mouse PFC lesioning ([@bhw229C30]). Animals were tested on two separate discrimination/reversals, the first using more discriminable stimuli and the second using more challenging stimuli (see Fig [2](#bhw229F2){ref-type="fig"}*i--l*, insets). The criterion for successful discrimination and reversal learning was ≥80% accuracy for two consecutive sessions. The dependent variables were trials to criterion, errors to criterion, correction trials to criterion, average correct response latency, and average reward retrieval latency. During reversal learning, perseverative errors (the number of incorrect responses made before achieving \>50% correct responding in session), learning errors (the number of incorrect responses made after achieving ≤50% correct responses in a session), and "perseveration index" (the number of correction trials as a ratio of errors) ([@bhw229C13]) were calculated. Figure 2.Performance of Df(h22q11)/+ and WT littermates on touchscreen assays. Data is presented as means ± SEM (*a*--*b*) TUNL -- delay challenge. The Df(h22q11)/+ showed higher accuracies (*a*) and required fewer correction trials (*b*) at longer delays. This effect was reproducible (see [Supplementary Fig. S4d--e](http://CERCOR.oxfordjournals.org/lookup/suppl/doi:10.1093/cercor/bhw229/-/DC1)). (*c*--*d*) TUNL -- separation challenge. No effects of genotype. (*e*--*f*) 5-CSRTT. No effect on accuracy (*e*). Following extensive training (\>100) sessions the Df(h22q11)/+ showed a duration-independent decrease in the number of omissions (*f*) when tested on 140-trial sessions. (*g*) PAL. No effects of genotype. (*h*) Extinction learning. No effect of genotype. (*i*--*l*) Discrimination learning and reversal learning. In the initial easy discrimination (i) and reversal challenge (k), the Df(h22q11)/+ showed improved learning. In a second more challenging discrimination (j) and reversal challenge (l) there were no effects of genotype. Insets depict the stimuli. Asterisk denote differences at which *p* \< 0 .05 (\*p \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001).

#### Touchscreen extinction learning {#bhw229s2b_2b}

Extinction of appetitive responding is dependent on the PFC, striatum and amygdala ([@bhw229C70]), areas disrupted in mouse models of 22q11.2DS ([@bhw229C24]). The task is extensively described elsewhere ([@bhw229C55]). In brief, animals were initially trained to respond to a single-white square stimulus within 10 s for reward. Animals were subsequently tested on extinction learning. During extinction learning, touches to the white-square stimulus resulted in the removal of the stimulus in the absence of rewards and conditioned reinforcers. The dependent variables were percent stimulus responses, response latency, and blank touches (during the ITI when no stimulus was shown).

### Working and Short-Term Memory {#bhw229s2b_3}

#### Touchscreen delayed non-match to location (rTUNL) {#bhw229s2b_3a}

The rTUNL task measures working memory and pattern separation, which are dependent upon the mPFC ([@bhw229C57]) and hippocampus ([@bhw229C84]). The rat version of the task is described elsewhere ([@bhw229C65]). Here we use a simplified version of the task ([@bhw229C41]) (see Supplementary Methods). Animals were tested on separate tests of increasing delays (2, 4, 6, 8 s) and increasing stimuli separations (small, large). To assess possible genotype differences in the use of mediating strategies, animals were again tested on the 6 s delay with sessions being video-recorded and behaviors during the delay were scored and cost/benefit scores were analyzed ([@bhw229C84]) using JWatcher (version 1.0). See supplementary methods for detailed protocol.

#### T-maze delayed non-match to location {#bhw229s2b_3b}

One cohort was assessed in an automated version of the task (using 10, 30, 60 s delays). Two further cohorts were assessed in a hand-run version of the task using a protocol kindly shared by Joshua Gordon (Columbia University) ([@bhw229C83]; [@bhw229C80]). In the hand-run experiment, the first cohort remained group-housed while the second cohort was single-housed 7 weeks to the beginning of training ([@bhw229C87]). Other groups have reported T-maze non-match to sample impairment in 22q11.2DS models using single-housed animals. The second cohort was therefore single-housed to evaluate the role of housing condition in a possible phenotype. See Supplementary Methods for detailed protocol.

#### Y-maze spontaneous alternation {#bhw229s2b_3c}

The task is sensitive to rodent models of schizophrenia ([@bhw229C7]) and is extensively described elsewhere ([@bhw229C21]). The sequence or arms entered was recoded and analyzed by Ethovision XT 8.5 (Noldus, Nottingham, UK) during a 15 min session. The alternation rate was calculated as the number of alternations (e.g., ABC is an alternation, ABA is not) divided by the total number of alternation opportunities (i.e., the total number of arm entries minus two). The total distance traveled was also calculated for each mouse.

#### Radial-arm maze {#bhw229s2b_3d}

The procedure is sensitive to mouse models of schizophrenia and is extensively described elsewhere ([@bhw229C38]). The main dependent variable was percent working memory errors, calculated as the number of re-entries into baited arms as a ratio of the number of arm entries.

### Long-Term Memory {#bhw229s2b_4}

#### Touchscreen paired-associate learning (PAL) {#bhw229s2b_4a}

The rPAL task measures visuospatial learning which is impaired in 22q11.2DS ([@bhw229C6]) and schizophrenia ([@bhw229C3]). The task is extensively described elsewhere ([@bhw229C34]). In rats, performance is impaired by hippocampal ([@bhw229C85]) and mPFC ([@bhw229C57]) lesions. Robust learning impairments in this task has been observed in an alternative transgenic mouse model of schizophrenia ([@bhw229C63]). Animals were tested for 70 sessions and and the data was collapsed in 5-session bins for analyses. The dependent variables percent accuracy, correction trials, correct and incorrect response latencies.

#### Fear-conditioning {#bhw229s2b_4b}

Impaired contextual and auditory fear-conditioning have been observed in a 22q11.2DS mouse model ([@bhw229C83]). The task is extensively described elsewhere ([@bhw229C58]).

#### Water maze {#bhw229s2b_4c}

The procedure is extensive described elsewhere ([@bhw229C68]). Separate cohorts of 10-week and 25-week old animals were tested with 4 and 6 acquisition days, respectively, followed by a probe trial 24 h later. Data were analyzed using Ethovision 3.0 (Noldus, Wageningen, The Netherlands).

#### Novel object recognition {#bhw229s2b_4d}

The task has been described previously ([@bhw229C88]). Animals were tested on 3, 8, 14, and 24 h delays. Video analyses of behavior were made by an experimenter blind to the genotype and location of the novel object using JWatcher (version 1.0). For each animal, the discrimination ratio (time spent exploring the novel object divided by the total time spent exploring), object exploration time in the sample-phase, and object biases were calculated.

Statistical Analyses {#bhw229s3}
--------------------

Data was analyzed through one-way ANOVA with genotype as between-subjects variable or repeated-measures ANOVA with genotype (and sex, where appropriate) as between-subject variable(s) and session, delay, stimulus duration, learning phase or stimulus separation as the within-subjects variable. Significant interactions where followed by one-way ANOVA. See Result for experiment-specific information. Analyses were done using SPSS (v21.0, IBM Corp, Armonk, NY).

Results {#bhw229s4}
=======

See Table [1](#bhw229TB1){ref-type="table"} for a summary of the results in the complete test battery. See [Table S1](http://CERCOR.oxfordjournals.org/lookup/suppl/doi:10.1093/cercor/bhw229/-/DC1) for overall average response latencies and reward retrieval latencies during touchscreen cognitive tests.

Attention and Behavioral Inhibition {#bhw229s4a}
-----------------------------------

### 5-CSRTT {#bhw229s4a_1}

The data was analyzed by mixed model ANOVAs. In short sessions with decreasing SDs ([Fig. S1a--b](http://CERCOR.oxfordjournals.org/lookup/suppl/doi:10.1093/cercor/bhw229/-/DC1)) there was no effect of genotype on accuracy (genotype: *F*~1,30~ = 0.240, *p* = 0.877; genotype × SD: *F*~6,180~ = 1.141, *p* = 0.340) or omissions (genotype: *F*~1,30~ = 0.235, *p* = 0.631; genotype × SD: F~6,180~ = 0.591, *p* = 0.737). There were no effects of genotype or genotype × SD interaction on any other behavioral measure (all *p* ≥ 0.193). When increasing the delay, there was no effect of genotype on premature responses ([Fig. S1c](http://CERCOR.oxfordjournals.org/lookup/suppl/doi:10.1093/cercor/bhw229/-/DC1); genotype: *F*~1,30~ = 0.240, *p* = 0.878; genotype × SD; *F*~4,120~ = 1.102, *p* = 0.359). There were no other effects of genotype or genotype × SD interactions (all *p* ≥ 0.055). Tests on long sessions (140 trials) following extensive training (\>100 session) showed an improved performance in the Df(h22q11)/+ with the transgenic making fewer omissions (Fig. [2](#bhw229F2){ref-type="fig"}*e--f*; genotype: *F*~1,30~ = 12.134, p = 0.002). On response latencies, there was a genotype × SD interaction (*F*~3,90~ = 6.467, *p* \< 0.001) with Df(h22q11)/+ animals showing faster responses at the 2 s SD (*F*~1,30~ = 5.384, *p* = 0.027; data not shown). There were no other effects of genotype or genotype × SD interactions (all *p* ≥ 0.287).

### Rodent Psychomotor Vigilance Task {#bhw229s4a_2}

There was no effect of genotype on premature responses during task acquisition ([Fig. S2a--c](http://CERCOR.oxfordjournals.org/lookup/suppl/doi:10.1093/cercor/bhw229/-/DC1); Mixed model ANOVA, effect of genotype: *F*~1,27~ = 0.483, *p* = 0.493; interaction effect genotype × session *F*~6,162~ = 0.703, *p* = 0.648). There were no effects of genotype on accuracy, omissions or average correct response latencies (Mixed model ANOVA or between-subject ANOVA, all *p* ≥ 0.333). Increasing the variable interval revealed a non-significant trend for the Df(h22q11)/+ mutant to make more premature responses than the WT (Fig. [3](#bhw229F3){ref-type="fig"}*g*; Mixed model ANOVA, effect of genotype: *F*~2,54~ = 3.805, *p* = 0.062; interaction effect genotype × interval: *F*~2,54~ = 0.375, *p* = 0.689). Figure 3.Performance of Df(h22q11)/+ and WT littermates on non-touchscreen assays. Data is presented as means ± SEM. (*a*--*b*) Hand-run T-maze. Df(h22q11)/+ mice required more sessions to acquire T-maze alternation criterion (*a*). No effect of genotype on tests of variable delays (*b*). Broken line represents random responding. (*c*) Automated T-maze. No effects of genotype. (*d*) Novel object recognition. No effects of genotype. (*e--f*) Water maze. No significant genotype differences in 10-week old animals on task acquisition (*e*) or a 24 h probe test (*f*). No effects were observed in 10-week old animals (see [Supplementary Fig. S4a-b](http://CERCOR.oxfordjournals.org/lookup/suppl/doi:10.1093/cercor/bhw229/-/DC1)). (*g*) Psychomotor vigilance task. No effect of genotype on probe-tests of impulsive-like behavior. (*h*) Y-maze. No effects of genotype. Broken line represents random responding. (*i*) Auditory fear conditioning. No effect of genotype (*j*) Context-dependent fear conditioning. No effect of genotype. (*k*) Radial arm-maze. No effect of genotype. Asterisk denote differences at which *p* \< 0.05.

Learning and Cognitive Flexibility {#bhw229s4b}
----------------------------------

### Visual Discrimination and Reversal Learning {#bhw229s4b_1}

The data was analyzed by one-way between-subjects ANOVAs. In the first discrimination, the Df(h22q11)/+ mice required fewer trials (Fig. [2](#bhw229F2){ref-type="fig"}*i*; *F*~1,30~ = 4.793, *p* = 0.036) and made fewer incorrect responses (*F*~1,30~ = 6.101, *p* = 0.019). Genotype did not affect correction trials or latency measures (all *p* ≥ 0.345). In the first reversal (Fig. [2](#bhw229F2){ref-type="fig"}*k*), the mutant required fewer trials (*F*~1,30~ = 11.769, *p* = 0.002) and incorrect responses to criterion (*F*~1,30~ = 9.771, *p* = 0.004). Df(h22q11)/+ mice made fewer late errors (*F*~1,30~ = 12.556, *p* = 0.001) but not early errors (*F*~1,30~ = 0.98, *p* = 0.757). Again, genotype failed to affect correction trials and latency measures (all *p* ≥ 0.172). A second test using less discriminable stimuli showed no effect of genotype on discrimination (Fig. [2](#bhw229F2){ref-type="fig"}*j*) or reversal learning (Fig. [2](#bhw229F2){ref-type="fig"}*l*; all *p* ≥ 0.127).

### Extinction Learning {#bhw229s4b_2}

Genotype did not affect extinction learning (Fig. [2](#bhw229F2){ref-type="fig"}*h*; Mixed model ANOVA, effect of genotype: *F*~9,270~ = 0.118, *p* = 0.734; interaction effect genotype × session: *F*~9,270~ = 1.820, *p* = 0.065).

Working and Short-Term Memory {#bhw229s5}
-----------------------------

### Water Maze {#bhw229s5a}

In 10-week old animals (Fig. [3](#bhw229F3){ref-type="fig"}*e--f*), there was no effect of genotype on acquisition (Mixed model ANOVA, effect of genotype: *F*~1,30~ = 2.763, *p* = 0.107; interaction effect genotype × session: *F*~3,90~ = 0.856, *p* = 0.467) or delay-probe (Between-subjects ANOVA, *F*~1,30~ = 1.754, *p* = 0.195). There was also no effect of genotype in 25-week old animals ([Fig. S4a--b](http://CERCOR.oxfordjournals.org/lookup/suppl/doi:10.1093/cercor/bhw229/-/DC1). all *p* ≥ 0.180).

### Y-maze Spontaneous Alternation {#bhw229s5b}

There was no effect of genotype on alternation rate (Fig. [3](#bhw229F3){ref-type="fig"}*h*; Between-subjects ANOVA, *F*~1,29~ = 2.869, *p* = 0.101).

### Radial-arm Maze {#bhw229s5c}

There was no effect of genotype on working memory errors over 10 test session (Fig. [3](#bhw229F3){ref-type="fig"}*k*; Mixed model ANOVA, effect of genotype: *F*~1,30~ = 0.282, *p* = 0.599; interaction effect genotype × session: *F*~9,270~ = 0.740, *p* = 0.672).

### Trial-unique Non-match to Sample {#bhw229s5d}

The Df(h22q11)/+ showed higher accuracies relative to the WT when manipulating the delay (Fig. [2](#bhw229F2){ref-type="fig"}*a*; Mixed model ANOVA, effect of genotype: *F*~1,30~ = 5.567, *p* = 0.025; interaction effect genotype × delay: *F*~3,90~ = 1.090, *p* = 0.357). Df(h22q11)/+ mice required fewer correction trials (Fig. [2](#bhw229F2){ref-type="fig"}*b*; Mixed model ANOVA, interaction effect genotype × delay: *F*~3,90~ = 4.094, *p* = 0.009) at the 6 s and 8 s delays (Between-subjects ANOVAs, *p* ≤ 0.017). Tests of pattern separation showed no effect of genotype (Fig. [2](#bhw229F2){ref-type="fig"}*c--d*; all *p* ≥ 0.832). In video analyses of mediating behaviors, Df(h22q11)/+ mice again outperformed WTs at the 6 s delay ([Fig. S4d--e](http://CERCOR.oxfordjournals.org/lookup/suppl/doi:10.1093/cercor/bhw229/-/DC1); Mixed model ANOVA, effect of genotype on accuracy: *F*~1,30~ = 4.879, *p* = 0.035; correction trials: *F*~1,30~ = 7.879, *p* = 0.009). There were no genotype differences in cost/benefit scores for any behavior ([Fig. S3](http://CERCOR.oxfordjournals.org/lookup/suppl/doi:10.1093/cercor/bhw229/-/DC1)).

### T-maze Delayed Non-match to Location {#bhw229s5e}

There was no effect of housing-condition on performance (all *p* ≥ 0.509) and groups were collapsed for analyses. In acquisition, the Df(h22q11)/+ mouse showed slower learning relative to the WT (Fig. [3](#bhw229F3){ref-type="fig"}*a*; Between-subjects ANOVA, effect of genotype: *F*~1,43~ = 4.579, *p* = 0.038). Genotype did not affect performance in tests of 10 s, 60 s, 120 s, and 240 s delays (Fig. [3](#bhw229F3){ref-type="fig"}*b*; Mixed model ANOVA, effect of genotype: *F*~1,43~ = 1.719, *p* = 0.197; interaction effect genotype × delay: *F*~3,129~ = 0.864, *p* = 0.462). Further tests using 10 s and 90 s delays revealed no genotype differences ([Fig. S4c](http://CERCOR.oxfordjournals.org/lookup/suppl/doi:10.1093/cercor/bhw229/-/DC1)). There were no effects of genotype in the automated T-maze task (Fig. [3](#bhw229F3){ref-type="fig"}*c*; all *p* ≥ 0.372).

### Fear-conditioning {#bhw229s5f}

The data was analyzed by mixed model ANOVAs. In the auditory cue condition, there were no effects of genotype on freezing (Fig. [3](#bhw229F3){ref-type="fig"}*i*; genotype, pre-CS: *F*~1,46~ = 0.405, *p* = 0.528; CS: *F*~1,46~ = 2.046, *p* = 0.159). Males were more immobile than females (data not shown; sex, Pre-CS: *F*~1,46~ = 5.835, *p* = 0.020; CS: *F*~1,46~ = 4.501, *p* = 0.039). Separate analyses by sex showed no effect of genotype (*p* ≥ 0.280). In the context condition, there were no effects of genotype (Fig. [3](#bhw229F3){ref-type="fig"}*j*; *F*~1,38~ = 0.975, *p* = 0.330) or sex (*F*~1,38~ = 1.904, *p* = 0.176).

Long-Term Memory {#bhw229s6}
----------------

### Paired Associate Learning {#bhw229s6a}

Data was analyzed by mixed model ANOVAs. There was no effect of genotype on accuracy (Fig. [2](#bhw229F2){ref-type="fig"}*g*; genotype: *F*~1,26~ = 0.679, *p* = 0.417; genotype × session: *F*~13,338~ = 0.481 *p* = 0.935), correction trials (genotype: *F*~1,26~ = 0.236, *p* = 0.631; genotype × session: *F*~13,390~ = 0.528 *p* = 0.907; data not shown) or latency measures (*p* ≥ 0.406).

### Novel Object Recognition {#bhw229s6b}

Genotype had no effect on novel object recognition at any delay (Fig. [3](#bhw229F3){ref-type="fig"}*d*; Mixed model ANOVA, effect of genotype: *F*~1,24~ = 0.244, *p* = 0.625; interaction effect genotype × delay: *F*~3,72~ = 0.057, *p* = 0.982).

Discussion {#bhw229s7}
==========

This report represents a multi-site evaluation of cognitive functioning in a 22q11.2DS mouse model by several partners in the NEWMEDS collaboration. It is the most comprehensive evaluation of cognition in a 22q11.2DS mouse model to date (Table [1](#bhw229TB1){ref-type="table"}). We selected a set of behavioral tests that have been shown to be sensitive to manipulations relevant for the 22q11.2DS and schizophrenia. These assays each evaluates individually distinct yet on a broader level partially overlapping cognitive functions and have demonstrated sensitivity to manipulations of PFC, hippocampal, DA and glutamate systems, as well as transgenic mouse models of neuropsychiatric disorders, including schizophrenia ([@bhw229C12]; [@bhw229C88]; [@bhw229C85]; [@bhw229C30]; [@bhw229C63]; [@bhw229C26]; [@bhw229C57]).

We found that the Df(h22q11)/+ mutant, in agreement with previous reports on 22q11.2DS models, shows impairments or trends towards impairments in several behavioral assays relevant to the cognitive impairments of neuropsychiatric disorders. This includes a deficit in acquisition of a T-maze non-match-to-sample task as well as non-significant trends towards impaired spatial memory in the Y-maze and water maze. The Df(h22q11)/+ mouse also showed trends towards increased impulsive responding in the psychomotor vigilance task and impaired auditory cue fear-conditioning.

However, the Df(h22q11)/+ mice showed normal performance in a range of other assays. This includes normal performance on object recognition, paired-associates learning, extinction learning, and contextual fear-conditioning. Improved performance was observed on cognitive flexibility (reversal learning), attention (5-CSRTT), and touchscreen spatial working memory (TUNL). In sum, although the Df(h22q11)/+ mouse model has been shown to recapitulate certain sensory and psychomotor phenotypes with relevance for schizophrenia ([@bhw229C90]), and minor cognitive deficits were observed in this study, it fails to mimic the extent of cognitive impairment observed in human 22q11.2 deletion carriers and schizophrenia patients. Considering possible reasons for the apparent mismatch between the CNS changes and the broad lack of behavioral effects, it is most unlikely that it results from a lack of statistical power or sensitivity of the behavioral assays, as these assays have revealed deficits using other lines of genetically modified mice ([@bhw229C12]; [@bhw229C4]; [@bhw229C72]; [@bhw229C2]; [@bhw229C18]; [@bhw229C63]; [@bhw229C73]; [@bhw229C71]; [@bhw229C64]). It remains possible that functional compensatory changes protect the animals from critical neuronal molecular effects and profound cognitive impairments. Such compensation is not obviously present in 22q11.2DS and schizophrenia patients. On the other hand, it is also possible that the neurobiological changes seen in the model are insufficient to produce profound deficits. It is important to keep in mind that the 22q11.2 microdeletion has incomplete penetrance in humans and syndrome expression presumably depends on the complete genetic makeup in concert with environmental influences. Thus, the Df(h22q11)/+ mouse may more appropriately be thought of as a liability model rather than a disease model.

Earlier studies indicate that 22q11.2DS models with overlapping heterozygote deletions showed impaired ([@bhw229C83]; [@bhw229C36]) or trends towards impaired ([@bhw229C80]) spatial learning in the T-maze. In agreement with these earlier studies, we saw impaired acquisition learning in this task. This mild effect was transient, however; when mice were subsequently tested on the same delay used during acquisition, there was no impairment. Furthermore, the impairment could not be re-instated by challenging the animals further with longer delays. The ability of Df(h22q11)/+ mice to perform well on longer delays suggests that these animals do not have a working memory impairment per se; instead the initial mild deficit, which was present on day one of testing, may be more related to the propensity of animals to non-match, or other nonspecific performance factors. There were no significant effects of genotype in the automated version of the task. The data therefore do not convincingly support that the Df(h22q11)/+ mouse combined with T-maze testing might serve as a useful model for assessing the effects of cognitive enhancing drugs on working memory.

We observed trends toward impairments in auditory fear-conditioning and in the water maze when tested at 10 and 25 weeks of age. Previous studies of 22q11.2DS models have reported inconsistent results in these tasks. The Df(16)A^+/−^ and Df1/+ mice ([@bhw229C67]; [@bhw229C83]) had deficits in contextual fear-conditioning following a 24 h delay. The Df(16)A^+/−^ mouse ([@bhw229C83]) also showed reduced auditory fear-conditioning. However, the Df1/+ mouse had normal auditory fear-conditioning and normal contextual fear-conditioning using a 1 h delay ([@bhw229C67]). Similarly, no auditory or contextual fear conditioning deficits were present in the LgDel mouse ([@bhw229C53]) or in mice with the smaller *Znf74-Ctp* deletion ([@bhw229C42]). In the water-maze, 16--20 weeks old Df(16)1/+ mice but not 6--8 week old Df(16)1/+ mice showed spatial learning deficits ([@bhw229C23]) and no impairment was observed in Df(16)A^+/−^ mutants at 5--7 months of age ([@bhw229C22]).

The Df(h22q11)/+ mutant showed improved discrimination and reversal learning when challenged with an easily discriminable stimulus pair, yet no effect of genotype was observed when tested using a less discriminable stimulus pair. In contrast, the LgDel mouse was shown to display impaired touchscreen discrimination and reversal learning ([@bhw229C59]). [@bhw229C59] observed large performance variability in their LgDel mutants relative to WT animals. Here, many transgenic animals displayed behavior comparable to WTs and the overall impairment on reversal learning appeared driven by a subgroup of mutants. There are as yet no reports of such heterogeneity in the Df(16)1/+ , Df(16)A^+/−^ or Df1/+ mutants, and we did not observe it in Df(h22q11)/+ mice. Furthermore, although the LgDel mouse showed an increase in overall incorrect responses, the mutant also showed a decrease in early perseverative-like errors, most relevant for modeling prefrontal dysfunction and cognitive inflexibility impairment of psychiatric disorders, including schizophrenia ([@bhw229C39]; [@bhw229C25]; [@bhw229C20]). Other factors that may explain the contrasting behavioral phenotypes of the LgDel and Df(h22q11)/+ models (or other behavioral discrepancies observed across laboratories in the independently generated 22q11.2DS mouse models) include the different background strains, ages, sex, and possible protocol differences, including the use of different stimuli, housing conditions and training protocols.

The Df(h22q11)/+ mouse also showed improved performance in the TUNL test of working memory and the 5-CSRTT test of attention (following extensive training). A tentative suggestion is that these effects may be produced by COMT haploinsuffiency. Cognitive abilities are related to a PFC-DA inverted-U curve whereby low levels of increased stimulation at the D~1~ receptor can improve performance ([@bhw229C45]). In both humans and rodents, COMT inhibition can improve cognitive flexibility, attention, and working memory ([@bhw229C86]; [@bhw229C48]). Decreased COMT activity through the COMT val^108/158^ allele has been associated with elevated cortical DA ([@bhw229C46]), improved cognitive flexibility ([@bhw229C54]), working memory and attention ([@bhw229C9]; [@bhw229C15]). COMT heterozygous mice have shown increased PFC-DA levels ([@bhw229C28]), improved attentional set-shifting ([@bhw229C74]) and working memory ([@bhw229C66]). Elevated PFC-DOPAC is also observed in the Df(h22q11)/+ mouse ([@bhw229C90]). Mouse and human COMT orthologs also show radical differences in enzymatic activity ([@bhw229C17]) which may be related the divergent cognitive phenotypes of 22q11.2 deletion carriers and the Df(h22q11)/+ mouse. Thus, improved performance on tests of executive functioning in the Df(h22q11)/+ mutant as well as the lack of effect of genotype in many assays could be related to COMT heterozygosity and increased PFC-DA levels overshadowing putative detrimental effects of further allelic insufficiencies on cognition in this model.

The 22q11DS Mouse Model as a Translational Tool for Psychiatric Drug Discovery {#bhw229s7a}
------------------------------------------------------------------------------

Being the strongest known genetic risk factor for schizophrenia, the 22q11.2DS is of considerable interest for translational research as it may allow for a model with good construct validity when probing the genetic basis of schizophrenia-relevant cognitive impairments. Our findings nevertheless suggest that deletion of the relevant chromosomal segment in the mouse confer a mild phenotype that fails to mimic the extent of the human cognitive impairment. There are differences within the orthologous regions in mice (MMU16) and humans (22q11.2) that may be involved in the lack of translation of the complete cognitive phenotype. This includes several genomic rearrangements in 22q11.2 segment relative to the mouse MMU16, and the low-copy repeats of the 22q11.2 region thought to infer segment instability is absent on the rodent MMU16 ([@bhw229C11]). The mouse do not carry a CLTCL ortholog for which hemizygosity has been linked to some primarily non-cognitive 22q11.2DS phenotypes ([@bhw229C81]; [@bhw229C32]). Mouse and human COMT orthologues also differ in enzymatic activity ([@bhw229C17]). Furthermore, in other constitutive mouse models of schizophrenia, haploinsufficiency can be insufficient in producing cognitive phenotypes of the disorders and homozygous mutants have been required ([@bhw229C62]). Homozygous 22q11.2DS mouse models are, however, unfortunately not presently viable. As stated above, the 22q11.2DS model may also be considered a liability model. Thus a more pronounced phenotype might appear in other assay conditions or in combination with additional environmental risk factors. For example, pubertal stress revealed latent neuropathological consequences of prenatal immune activation, another risk factor for schizophrenia ([@bhw229C27]). It may be that a similar approach is necessary for unmasking robust dysfunctions in the 22q11.2DS mouse model and other CNV models ([@bhw229C44]; [@bhw229C61]) where phenotypic expression within multiple domains of cognition can remain below threshold.

Yet it should be noted that current study is not a complete assessment of 22q11.2DS-relevant cognitive functions. For example, 22q11.2DS is associated with deficits in visual sustained attention as measured by Go/no-go or continuous performance tasks ([@bhw229C50]; [@bhw229C1]; [@bhw229C78]; [@bhw229C33]; [@bhw229C76]). Several 22q11.2DS mouse models ([@bhw229C42]; [@bhw229C67]; [@bhw229C53]; [@bhw229C83]), including the Df(h22q11)/+ mutant ([@bhw229C90]), also show sensorimotor gating deficits, considered a marker of pre-attentative information processing ([@bhw229C69]). Although the current battery did not include tests of visual sustained attention or motivational functioning, the demonstrated link between these domains and 22q11.2DS may warrant further behavioral study in the Df(h22q11)/+ mouse.

Conclusion {#bhw229s8}
==========

In agreement with the previous literature, the mouse model of 22q11.2DS showed some impairments or trends towards impairments in tasks of cognition. However, this extensive test battery indicates that the model does not mimic the extent of 22q11.2DS-related cognitive deficits as seen in affected human carriers. It may be that functional compensations protect the animals from profound cognitive deficits or that the genetic changes observed in this mutant are insufficient to produce major behavioral impairments unless they are exposed to additional risk factors. Possibilities remain that tests not included in the current study are sensitive to the genetic disruptions of the 22q.11.2DS model.

Supplementary Material {#bhw229s10}
======================

[Supplementary material can be found at: http://www.cercor.oxfordjournals.org/](http://CERCOR.oxfordjournals.org/lookup/suppl/doi:10.1093/cercor/bhw229/-/DC1)

###### Supplementary Data

The research leading to these results has received support from the Innovative Medicine Initiative Joint Undertaking under grant agreement No. 115008 of which resources are composed of EFPIA in-kind contribution and financial contribution from the European Union\'s Seventh Framework Programme (FP7/2007--2013). The Behavioural and Clinical Neuroscience Institute is co-funded by the Medical Research Council and the Wellcome Trust. The authors would like to thank Begoña Gamallo Lana, Edita Bulovaitė, Sueda Tunçak, Diab Ali, Maarten van Dijk and Andrée-Anne Berthiaume for skillful technical assistance. *Conflict of interest*: KF, JN, VN, JFB, PHL, TBS and MD are all employed by H. Lundbeck A/S. LMS and TJB consult for Campden Instruments, Ltd. FG is employed by Eli Lilly and Co. TWR discloses consultancy with Cambridge Cognition, Lilly, Lundbeck and GlaxoSmithKline, and has research grants with Lilly, Lundbeck and GlaxoSmithKline. *Conflict of Interest*: None declared.

[^1]: ^a^[@bhw229C23].

[^2]: ^b^[@bhw229C22].

[^3]: ^c^[@bhw229C83].

[^4]: ^d^[@bhw229C53].

[^5]: ^e^[@bhw229C67].

[^6]: ^f^[@bhw229C42].

[^7]: ^g^[@bhw229C91].

[^8]: ^h^[@bhw229C59].

[^9]: ^i^[@bhw229C80].

[^10]: ^j^[@bhw229C36].
